mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
2e-11 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
4e-11 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
3e-10 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
3e-10 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-09 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
4e-09 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
1e-08 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-08 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-08 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-08 |